Investor Expectations to Drive Momentum within AMN Healthcare Services, Cass Information, William Lyon Homes, AMAG Pharmaceuticals, Intersect ENT, and First Financial — Discovering Underlying Factors

Investor Expectations to Drive Momentum within AMN Healthcare Services, Cass Information, William Lyon Homes, AMAG Pharmaceuticals, Intersect ENT, and First Financial — Discovering Underlying Factors of Influence

NEW YORK, April 24, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of AMN Healthcare Services Inc (NYSE:AMN), Cass Information Systems, Inc (NASDAQ:CASS), William Lyon Homes (NYSE:WLH), AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG), Intersect ENT, Inc. (NASDAQ:XENT), and First Financial Bancorp. (NASDAQ:FFBC), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

AMN DOWNLOAD: http://Fundamental-Markets.com/register/?so=AMN
CASS DOWNLOAD:
http://Fundamental-Markets.com/register/?so=CASS
WLH DOWNLOAD:
http://Fundamental-Markets.com/register/?so=WLH
AMAG DOWNLOAD:
http://Fundamental-Markets.com/register/?so=AMAG
XENT DOWNLOAD:
http://Fundamental-Markets.com/register/?so=XENT
FFBC DOWNLOAD:
http://Fundamental-Markets.com/register/?so=FFBC

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine AMN Healthcare Services Inc (NYSE:AMN), Cass Information Systems, Inc (NASDAQ:CASS), William Lyon Homes (NYSE:WLH), AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG), Intersect ENT, Inc. (NASDAQ:XENT), and First Financial Bancorp. (NASDAQ:FFBC) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed April 20th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

AMN HEALTHCARE SERVICES INC (AMN) REPORT OVERVIEW

AMN Healthcare Services' Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, AMN Healthcare Services reported revenue of $509.08MM vs $487.86MM (up 4.35%) and basic earnings per share $0.86 vs $0.55 (up 56.36%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, AMN Healthcare Services reported revenue of $1,988.45MM vs $1,902.23MM (up 4.53%) and basic earnings per share $2.77 vs $2.21 (up 25.34%). AMN Healthcare Services is expected to report earnings on May 3rd, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.63. The estimated EPS forecast for the next fiscal year is $3.80 and is expected to report on February 21st, 2019.

To read the full AMN Healthcare Services Inc (AMN) report, download it here: http://Fundamental-Markets.com/register/?so=AMN

-----------------------------------------

CASS INFORMATION SYSTEMS, INC (CASS) REPORT OVERVIEW

Cass Information's Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, Cass Information reported interest income of $10.98MM vs $10.16MM (up 8.10%) and basic earnings per share $0.43 vs $0.53 (down 18.14%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Cass Information reported interest income of $41.98MM vs $39.93MM (up 5.13%) and basic earnings per share $2.04 vs $1.99 (up 2.51%).

To read the full Cass Information Systems, Inc (CASS) report, download it here: http://Fundamental-Markets.com/register/?so=CASS

-----------------------------------------

WILLIAM LYON HOMES (WLH) REPORT OVERVIEW

William Lyon Homes' Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, William Lyon Homes reported revenue of $624.64MM vs $473.25MM (up 31.99%) and basic earnings per share $0.32 vs $0.61 (down 47.54%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, William Lyon Homes reported revenue of $1,796.53MM vs $1,406.04MM (up 27.77%) and basic earnings per share $1.30 vs $1.62 (down 19.75%). William Lyon Homes is expected to report earnings on May 8th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.11. The estimated EPS forecast for the next fiscal year is $3.75 and is expected to report on February 19th, 2019.

To read the full William Lyon Homes (WLH) report, download it here: http://Fundamental-Markets.com/register/?so=WLH

-----------------------------------------

AMAG PHARMACEUTICALS, INC. (AMAG) REPORT OVERVIEW

AMAG Pharmaceuticals' Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, AMAG Pharmaceuticals reported revenue of $158.34MM vs $151.59MM (up 4.45%) and basic earnings per share $0.06 vs -$0.30. For the twelve months ended December 31st, 2017 vs December 31st, 2016, AMAG Pharmaceuticals reported revenue of $609.95MM vs $532.09MM (up 14.63%) and basic earnings per share -$5.71 vs -$0.07. AMAG Pharmaceuticals is expected to report earnings on May 1st, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was -$1.06. The estimated EPS forecast for the next fiscal year is -$1.62 and is expected to report on February 26th, 2019.

To read the full AMAG Pharmaceuticals, Inc. (AMAG) report, download it here: http://Fundamental-Markets.com/register/?so=AMAG

-----------------------------------------

INTERSECT ENT, INC. (XENT) REPORT OVERVIEW

Intersect ENT's Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, Intersect ENT reported revenue of $29.53MM vs $24.23MM (up 21.86%) and basic earnings per share -$0.10 vs -$0.17. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Intersect ENT reported revenue of $96.30MM vs $78.71MM (up 22.35%) and basic earnings per share -$0.56 vs -$0.89. Intersect ENT is expected to report earnings on May 1st, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was -$0.23. The estimated EPS forecast for the next fiscal year is -$0.18 and is expected to report on February 26th, 2019.

To read the full Intersect ENT, Inc. (XENT) report, download it here: http://Fundamental-Markets.com/register/?so=XENT

-----------------------------------------

FIRST FINANCIAL BANCORP. (FFBC) REPORT OVERVIEW

First Financial's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, First Financial reported interest income of $90.35MM vs $78.83MM (up 14.62%) and basic earnings per share $0.49 vs $0.40 (up 22.50%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, First Financial reported interest income of $333.07MM vs $305.95MM (up 8.87%) and basic earnings per share $1.57 vs $1.45 (up 8.28%). First Financial is expected to report earnings on July 24th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.37. The estimated EPS forecast for the next fiscal year is $2.31 and is expected to report on January 17th, 2019.

To read the full First Financial Bancorp. (FFBC) report, download it here: http://Fundamental-Markets.com/register/?so=FFBC

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at [email protected].

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: [email protected]

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at [email protected].

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.